http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2415927-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_668b08dfb09a8dcc548b4b3a2abcf5b2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H4-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-04 |
| filingDate | 2009-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_291dabee9280f2751649393e56683dd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d2f524c9de461701a2da21ff4423e14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d83120a9ef6688fee3d9af52a44188eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eab34d9c9e1110ecef37881c2042e54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_267a401b82c88d277a3f58a2a10da2c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89959feb6a2c3e32e78cdd28871221c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b0055cf18103d01931b9b2c3afd8922 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dda4a2483e8891ec9924cda1a481eb19 |
| publicationDate | 2011-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2415927-C1 |
| titleOfInvention | IN VITRO CULTIVATED PANAX GINSENG PG-1 (Panax ginseng C.A. Mey) CELL STRAIN - GINSENOSIDE PRODUCER |
| abstract | FIELD: medicine. ^ SUBSTANCE: in vitro cultivated ginseng HacroflineroPg-1 (Panax ginseng C And Mey) cell strain is deposited in the Russian Collection of Cultivated Seed Plant Cells under the Institution of the Russian Academy of Sciences K.A Timiryazev Plant Physiology Institute of the Russian Academy of Sciences, No. 68 - a producer of ginsenosides: compounds of Rg and Rb groups. During long-term cultivation (6-7 cycles), all seven ginsenosides characteristic for plants were shown stably. In the Pg-1 strain, synthesis of the Rb-group compounds and Re ginsenoside especially, has become more active. The relation of the Rg/Rb group compounds have been observed to be high enough and remained stable over a number consecutive cultivation cycles. The prepared Panax Ginseng Pg-1 strain synthesizes a complete formulation of the Rg and Rb group ginsenoside compounds and their significant amount - up to 4 % from a dry biomass of cells. The qualitative composition of all Rb and Rg-group ginsenoside compounds and their quantity has been equal to the values available in a wild-growing Panax Ginseng. ^ EFFECT: availability of the strain for making valuable biologically active compounds which are widely used in pharmaceutical industry and cosmetology. ^ 3 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2726067-C1 |
| priorityDate | 2009-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.